Gregory A. Johnson is a Principal Scientist in Process Development at Amgen, where they lead a team of scientists and collaborate with external CROs and CMOs on analytical method development and validation for drug substances and products. Previously, they served as a Sr. Scientist at Merck, contributing to regulatory filings and supporting development groups in various analytical studies. Gregory's academic background includes a Ph.D. in Biochemistry and Biophysics from Texas A&M University and dual undergraduate degrees in Biology and Chemistry from California State University-San Bernardino. Their expertise is recognized in both collaborative research and publication, with notable contributions to the Merck HIV franchise and the development of LUMAKRAS™.
This person is not in the org chart
This person is not in any teams
This person is not in any offices